Masahiro Tsuboi
MD, PhD
Vice President and Chief, Thoracic Surgery
👥Biography 个人简介
Masahiro Tsuboi was principal investigator of the ADAURA trial that established adjuvant osimertinib as the standard of care for resected EGFR-mutant NSCLC, demonstrating unprecedented disease-free survival improvement. This trial fundamentally changed the management of early-stage EGFR-mutant lung cancer. He continues to lead perioperative therapy studies in thoracic oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Masahiro Tsuboi 的研究动态
Follow Masahiro Tsuboi's research updates
留下邮箱，当我们发布与 Masahiro Tsuboi（National Cancer Center Hospital East）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment